Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

High-dose methotrexate in combination chemotherapy for small cell lung cancer.

High-dose methotrexate in combination chemotherapy for small cell lung cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • High-dose methotrexate in combination chemotherapy for small cell lung cancer. Abstract Text:

    f a grecoF A Greco,k r handeK R Hande,r l richardsonR L Richardson,r k oldhamR K Oldham,

    High-dose methotrexate and Leucovorin (calcium folinate) rescue was evaluated as induction chemotherapy in combination with cyclophosphamide, doxorubicin, and vincristine in 21 patients with extensive-stage small cell lung cancer. Nine (42%) of 21 had a complete remission. The median duration of remission has been short (5 months), and attempts are now under way to improve consolidation chemotherapy. In general, the degree of myelotoxicity was not increased by the high-dose methotrexate, although the antitumor activity of the combination appears enhanced. Attempts at further increasing the intensity of this regimen or comparative trials with other therapy appears warranted.

    High-dose methotrexate in combination chemotherapy for small cell lung cancer. Publishing Authors By Initials

    fa grecoFA Greco,kr handeKR Hande,rl richardsonRL Richardson,rk oldhamRK Oldham,

    For similar persons: age groups: adult: middle aged research abstracts see: persons: age groups: adult: middle aged research

    PUBMED ID PMID:

    MEDLINE DATE:

    High-dose methotrexate in combination chemotherapy for small cell lung cancer. Journal Published:

    PUBLICATION TYPE: Research Support, U.S. Gov't,

    Journal: Recent results in cancer research. Fortschritte de

    VOLUME: 74

    Page Numbers: 50-5

    Journal Abbreviation: Recent Results Cancer Res.

    ISSN: 0080-0015

    DAY: 13

    MONTH: 02

    YEAR: 1980

    High-dose methotrexate in combination chemotherapy for small cell lung cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 44671

    High-dose methotrexate in combination chemotherapy for small cell lung cancer. Keywords Mesh Terms:

    KEYWORDS: Middle Aged

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: High-dose methotrexate in combination chemotherapy for small cell lung cancer. Information

    Substance Name: Methotrexate

    Registry Number: 59-05-2

    Grant and Affiliation Information for High-dose methotrexate in combination chemotherapy for small cell lung cancer.

    AFFILIATION:

    Country: GERMANY, WEST

    GERMANY, WEST Research PublicationGERMANY, WEST Research Publication

    AGENCY: United States NCRR

    GRANT: 5M01 RR-95

    ACRONYM: RR

    MEDLINETA: Recent Results Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    High-dose methotrexate in combination chemotherapy for small cell lung cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News